BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

440 related articles for article (PubMed ID: 14579660)

  • 1. Liposomal amphotericin B treatment for rhinocerebral mucormycosis: how much is enough?
    Handzel O; Landau Z; Halperin D
    Rhinology; 2003 Sep; 41(3):184-6. PubMed ID: 14579660
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Treatment of invasive fungal sinusitis with liposomal amphotericin B: a report of four cases.
    Sungkanuparph S; Sathapatayavongs B; Kunachak S; Luxameechanporn T; Cheewaruangroj W
    J Med Assoc Thai; 2001 Apr; 84(4):593-601. PubMed ID: 11460976
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Liposomal amphotericin B in the treatment of severe fungal infections. Results of a clinical cohort trial].
    Rieger CT; Dittmer M; Ostermann H
    Dtsch Med Wochenschr; 2007 Oct; 132(40):2062-6. PubMed ID: 17899499
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Localized bilateral paranasal mucormycosis: a case in an immunocompetent patient.
    Park SK; Jung H; Kang MS
    Acta Otolaryngol; 2006 Dec; 126(12):1339-41. PubMed ID: 17101598
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Safe and successful endoarterial infusion of liposomal amphotericin B in treatment of mucormycosis.
    Mansueto P; Rizzo M; Affronti M; Malta R; Carmina E; Mansueto S; Masellis M; Rini GB
    New Microbiol; 2003 Oct; 26(4):395-8. PubMed ID: 14596351
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Pulmonary mucormycosis: benefit of aerosol amphotericin B?].
    Furco A; Mouchet B; Carbonnelle M; Vallerand H
    Rev Mal Respir; 2001 Jun; 18(3):309-13. PubMed ID: 11468594
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Comments on the treatment of rhinocerebral mucormycosis].
    Pardal Refoyo JL; Chocarro Martínez A; Brezmes Valdivieso MF
    Acta Otorrinolaringol Esp; 1997 Mar; 48(2):175-6. PubMed ID: 9198473
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Rhinocerebral mucormycosis following donor leukocyte infusion: successful treatment with liposomal amphotericin B and surgical debridement.
    Peñalver FJ; Romero R; Forés R; Cabrera R; Díez-Martin JL; Regidor C; Fernández MN
    Bone Marrow Transplant; 1998 Oct; 22(8):817-8. PubMed ID: 9827982
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Rhinocerebral mucormycosis acquired after a short course of prednisone therapy.
    Ferguson AD
    J Am Osteopath Assoc; 2007 Nov; 107(11):491-3. PubMed ID: 18057223
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Rhinocerebral mucormycosis. Therapy with amphotericin B lipid complex.
    Strasser MD; Kennedy RJ; Adam RD
    Arch Intern Med; 1996 Feb; 156(3):337-9. PubMed ID: 8572846
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Remission of invasive sinusal and pulmonary aspergillosis with liposomal amphotericin B in a patient with chronic lymphatic leukemia following failure with conventional amphotericin].
    Palacio C; Acebedo G; López A; Jodar JM
    Sangre (Barc); 1994 Oct; 39(5):389-92. PubMed ID: 7754445
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Rhinocerebral mucormycosis with orbital and intracranial extension: a case report and review of optimum management.
    Munir N; Jones NS
    J Laryngol Otol; 2007 Feb; 121(2):192-5. PubMed ID: 17134533
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Endoscopic management of rhinocerebral mucormycosis with topical and intravenous amphotericin B.
    Saedi B; Sadeghi M; Seilani P
    J Laryngol Otol; 2011 Aug; 125(8):807-10. PubMed ID: 21729440
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Toxicity, stability and pharmacokinetics of amphotericin B in immunomodulator tuftsin-bearing liposomes in a murine model.
    Khan MA; Owais M
    J Antimicrob Chemother; 2006 Jul; 58(1):125-32. PubMed ID: 16709592
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Successful management of cerebral and pulmonary mucormycosis with liposomal amphotericin B in a 28-year-old woman with acute lymphoblastic leukemia.
    Salonen JH
    Acta Biomed; 2006; 77 Suppl 2():28-31. PubMed ID: 16918065
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Neonatal candidiasis and liposomal amphotericin B treatment: our experience].
    Carrasco Sánchez P; Castillo Montero ML; Bejarano Palma A; López Sanz A; Santano Gallinato M; Sáenz Reguera C; Durán de Vargas L; González-Meneses A
    An Esp Pediatr; 1999 Sep; 51(3):273-80. PubMed ID: 10575751
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Use of liposomal amphotericin B in bone marrow transplant.
    Sastry PS; Parikh PM; Kulkarni PS; Bhagwat R; Gadade H
    J Postgrad Med; 2005; 51 Suppl 1():S49-52. PubMed ID: 16519256
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A mucormycosis case treated with a combination of caspofungin and amphotericin B.
    Kazak E; Aslan E; Akalın H; Saraydaroğlu O; Hakyemez B; Erişen L; Yazıcı B; Gürcüoğlu E; Yılmaz E; Ener B; Helvacı S
    J Mycol Med; 2013 Sep; 23(3):179-84. PubMed ID: 23856448
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Rhinocerebral mucormycosis treated with 32 gram liposomal amphotericin B and incomplete surgery: a case report.
    Cagatay AA; Oncü SS; Calangu SS; Yildirmak TT; Ozsüt HH; Eraksoy HH
    BMC Infect Dis; 2001; 1():22. PubMed ID: 11737868
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Successful treatment of mucormycosis after kidney transplantation.
    Miladipour A; Ghanei E; Nasrollahi A; Moghaddasi H
    Iran J Kidney Dis; 2008 Jul; 2(3):163-6. PubMed ID: 19377232
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.